Ensuring the safety and efficacy of new biotechnological treatments requires comprehensive clinical trials and stringent regulatory oversight. This involves multiple phases of testing to evaluate the treatment's safety, effectiveness, and potential side effects. Regulatory bodies like the FDA (Food and Drug Administration) and EMA (European Medicines Agency) play a crucial role in approving and monitoring these treatments.
